Closure of patent foramen ovale in patients with orthodeoxia-platypnea using the amplatzer devices.
We present a series of four patients with orthodeoxia-platypnea who underwent successful transcatheter closure of their patent foramen ovale using the Amplatzer devices (Amplatzer septal occluder/Amplatzer PFO occluder). The average saturation increased from 81% to 96% with complete resolution of symptoms. The Amplatzer devices are safe and effective treatment options for patients with orthodeoxia-platypnea.
Waight
D J
DJ
Section of Pediatric Cardiology, University of Chicago Children's Hospital, Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA.
Cao
Q L
QL
Hijazi
Z M
ZM
D000368:Aged; D000369:Aged, 80 and over; D004417:Dyspnea / Q000209:etiology*; D017548:Echocardiography, Transesophageal; D004621:Embolization, Therapeutic / Q000295:instrumentation; D005260:Female; D006344:Heart Septal Defects, Atrial / Q000150:complications / Q000628:therapy*; D006801:Humans; D000860:Hypoxia / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D011187:Posture; D019736:Prostheses and Implants